Fulacimstat (BAY1142524)

Phase 1Completed
0 watching 0 views this week๐Ÿ’ค Quiet
30
Hype Score

Development Stage

โœ“
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Clinical Trial, Phase I

Conditions

Clinical Trial, Phase I

Trial Timeline

Feb 12, 2018 โ†’ Mar 19, 2019

About Fulacimstat (BAY1142524)

Fulacimstat (BAY1142524) is a phase 1 stage product being developed by Bayer for Clinical Trial, Phase I. The current trial status is completed. This product is registered under clinical trial identifier NCT03402438. Target conditions include Clinical Trial, Phase I.

Hype Score Breakdown

Clinical
10
Activity
5
Company
7
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT03402438Phase 1Completed

Competing Products

20 competing products in Clinical Trial, Phase I

See all competitors